These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38608741)

  • 1. Early treatment with rifaximin during epileptogenesis reverses gut alterations and reduces seizure duration in a mouse model of acquired epilepsy.
    Kebede V; Ravizza T; Balosso S; Di Sapia R; Canali L; Soldi S; Galletti S; Papazlatani C; Karas PA; Vasileiadis S; Sforzini A; Pasetto L; Bonetto V; Vezzani A; Vesci L
    Brain Behav Immun; 2024 Jul; 119():363-380. PubMed ID: 38608741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an epilepsy-linked gut microbiota signature in a pediatric rat model of acquired epilepsy.
    Riva A; Sahin E; Volpedo G; Petretto A; Lavarello C; Di Sapia R; Barbarossa D; Zaniani NR; Craparotta I; Barbera MC; Sezerman U; Vezzani A; Striano P; Ravizza T
    Neurobiol Dis; 2024 May; 194():106469. PubMed ID: 38485093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1400W, a highly selective inducible nitric oxide synthase inhibitor is a potential disease modifier in the rat kainate model of temporal lobe epilepsy.
    Puttachary S; Sharma S; Verma S; Yang Y; Putra M; Thippeswamy A; Luo D; Thippeswamy T
    Neurobiol Dis; 2016 Sep; 93():184-200. PubMed ID: 27208748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL1-CXCR1/2 signaling is induced in human temporal lobe epilepsy and contributes to seizures in a murine model of acquired epilepsy.
    Di Sapia R; Zimmer TS; Kebede V; Balosso S; Ravizza T; Sorrentino D; Castillo MAM; Porcu L; Cattani F; Ruocco A; Aronica E; Allegretti M; Brandolini L; Vezzani A
    Neurobiol Dis; 2021 Oct; 158():105468. PubMed ID: 34358616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus.
    Li B; Ma Y; Wang X; Zhao D; Wang Z; Wang G; Li C; Yang L; Ji H; Liu K; Chen Q; Yang Y; Ma W; Du J; Ma L; Zhang L; Qiang Y
    Neurochem Res; 2024 Oct; 49(10):2726-2742. PubMed ID: 38935224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered cardiac structure and function is related to seizure frequency in a rat model of chronic acquired temporal lobe epilepsy.
    Powell KL; Liu Z; Curl CL; Raaijmakers AJA; Sharma P; Braine EL; Gomes FM; Sivathamboo S; Macefield VG; Casillas-Espinosa PM; Jones NC; Delbridge LM; O'Brien TJ
    Neurobiol Dis; 2021 Nov; 159():105505. PubMed ID: 34520843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visually or auditorily induced seizures involve the activation of nonhippocampal brain areas and hippocampal removal does not alleviate seizures in a mouse model of temporal lobe epilepsy.
    Bello ST; Xu S; Li X; Ren J; Jendrichovsky P; Jiang F; Xiao Z; Wan X; Chen X; He J
    Epilepsia; 2024 Jan; 65(1):218-237. PubMed ID: 38032046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol 24-hydroxylase is a novel pharmacological target for anti-ictogenic and disease modification effects in epilepsy.
    Salamone A; Terrone G; Di Sapia R; Balosso S; Ravizza T; Beltrame L; Craparotta I; Mannarino L; Cominesi SR; Rizzi M; Pauletti A; Marchini S; Porcu L; Zimmer TS; Aronica E; During M; Abrahams B; Kondo S; Nishi T; Vezzani A
    Neurobiol Dis; 2022 Oct; 173():105835. PubMed ID: 35932989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglia proliferation plays distinct roles in acquired epilepsy depending on disease stages.
    Di Nunzio M; Di Sapia R; Sorrentino D; Kebede V; Cerovic M; Gullotta GS; Bacigaluppi M; Audinat E; Marchi N; Ravizza T; Vezzani A
    Epilepsia; 2021 Aug; 62(8):1931-1945. PubMed ID: 34128226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifaximin alleviates MCD diet-induced NASH in mice by restoring the gut microbiota and intestinal barrier.
    Shu YY; Hu LL; Ye J; Yang L; Jin Y
    Life Sci; 2024 Nov; 357():123095. PubMed ID: 39368771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-modifying effects of sodium selenate in a model of drug-resistant, temporal lobe epilepsy.
    Casillas-Espinosa PM; Anderson A; Harutyunyan A; Li C; Lee J; Braine EL; Brady RD; Sun M; Huang C; Barlow CK; Shah AD; Schittenhelm RB; Mychasiuk R; Jones NC; Shultz SR; O'Brien TJ
    Elife; 2023 Mar; 12():. PubMed ID: 36892461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epileptogenesis and chronic seizures in a mouse model of temporal lobe epilepsy are associated with distinct EEG patterns and selective neurochemical alterations in the contralateral hippocampus.
    Arabadzisz D; Antal K; Parpan F; Emri Z; Fritschy JM
    Exp Neurol; 2005 Jul; 194(1):76-90. PubMed ID: 15899245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Various modifications of the intrahippocampal kainate model of mesial temporal lobe epilepsy in rats fail to resolve the marked rat-to-mouse differences in type and frequency of spontaneous seizures in this model.
    Klee R; Brandt C; Töllner K; Löscher W
    Epilepsy Behav; 2017 Mar; 68():129-140. PubMed ID: 28167446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diet composition and sterilization modifies intestinal microbiome diversity and burden of Theiler's virus infection-induced acute seizures.
    Zierath DK; Davidson S; Manoukian J; Knox KM; White HS; Meeker S; Ericsson A; Barker-Haliski M
    Epilepsia; 2024 Jun; 65(6):1777-1790. PubMed ID: 38491947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterising seizure development, behavioural comorbidities and neuroinflammation in a self-sustained electrical status epilepticus model of mesial temporal lobe epilepsy in C57BL/6J mice.
    Thergarajan P; Hudson MR; Carmichael I; Clasadonte J; Dedeurwaerdere S; O'Brien TJ; Jones NC; Ali I
    Neurobiol Dis; 2022 Jun; 168():105688. PubMed ID: 35288303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of diazepam during status epilepticus reduces development and severity of epilepsy in rat.
    Pitkänen A; Kharatishvili I; Narkilahti S; Lukasiuk K; Nissinen J
    Epilepsy Res; 2005 Jan; 63(1):27-42. PubMed ID: 15716080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with melatonin after status epilepticus attenuates seizure activity and neuronal damage but does not prevent the disturbance in diurnal rhythms and behavioral alterations in spontaneously hypertensive rats in kainate model of temporal lobe epilepsy.
    Petkova Z; Tchekalarova J; Pechlivanova D; Moyanova S; Kortenska L; Mitreva R; Popov D; Markova P; Lozanov V; Atanasova D; Lazarov N; Stoynev A
    Epilepsy Behav; 2014 Feb; 31():198-208. PubMed ID: 24440891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian clustering of spontaneous epileptic seizures emerges after pilocarpine-induced status epilepticus.
    Pitsch J; Becker AJ; Schoch S; Müller JA; de Curtis M; Gnatkovsky V
    Epilepsia; 2017 Jul; 58(7):1159-1171. PubMed ID: 28542864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translational potential of the ghrelin receptor agonist macimorelin for seizure suppression in pharmacoresistant epilepsy.
    Buckinx A; Pierre A; Van Den Herrewegen Y; Guenther E; Gerlach M; Van Laethem G; Kooijman R; De Bundel D; Smolders I
    Eur J Neurol; 2021 Sep; 28(9):3100-3112. PubMed ID: 34157194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy.
    Löscher W
    Epilepsy Res; 2002 Jun; 50(1-2):105-23. PubMed ID: 12151122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.